|
|
Volumn 84, Issue 9, 1995, Pages 1090-1093
|
|
Preformulation studies of a novel HIV protease inhibitor, AG1343
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [2 HYDROXY 5 (3 HYDROXY 2 METHYLPHENYL) 5 OXO 3 [(PHENYLTHIO)METHYL] 4 AZAPENTYL]DECAHYDROISOQUINOLINE 3 N TERT BUTYL CARBOXAMIDE METHANESULFONATE;
ACETONITRILE;
ALCOHOL;
BETA CYCLODEXTRIN;
CARBOXYMETHYLCELLULOSE;
CREMOPHOR;
GELUCIRE;
GLUCOSE;
HYDROCHLORIC ACID;
METHANOL;
NELFINAVIR;
PROPYLENE GLYCOL;
PROTEINASE INHIBITOR;
SOLVENT;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL EXPERIMENT;
ARTICLE;
CLINICAL TRIAL;
DIFFERENTIAL SCANNING CALORIMETRY;
DOG;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PARTITION COEFFICIENT;
PH;
PHASE 1 CLINICAL TRIAL;
RAT;
THERMODYNAMICS;
VIRUS INHIBITION;
ANIMAL;
ANTIVIRAL AGENTS;
BIOLOGICAL AVAILABILITY;
CALORIMETRY, DIFFERENTIAL SCANNING;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DOGS;
DRUG STABILITY;
HIV PROTEASE INHIBITORS;
HYDROGEN-ION CONCENTRATION;
MICROSCOPY, POLARIZATION;
NELFINAVIR;
RATS;
RATS, SPRAGUE-DAWLEY;
SOLUBILITY;
X-RAY DIFFRACTION;
|
|
EID: 0029155786
PISSN: 00223549
EISSN: 15206017
Source Type: Journal
DOI: 10.1002/jps.2600840911 Document Type: Article |
|
Times cited : (38)
|
|
References (10)
|
